22h
CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
Reported positive Phase 2b RewinD-LB clinical data at CTAD 2025; additional analyses to be presented at AD/PD 2026 Obtained ...
The Fuse EDA AI Agent manages workflows across Siemens' comprehensive EDA portfolio, delivering automation that accelerates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results